1. Home
  2. NRIM vs HELP Comparison

NRIM vs HELP Comparison

Compare NRIM & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NRIM

Northrim BanCorp Inc

N/A

Current Price

$27.25

Market Cap

602.6M

Sector

Finance

ML Signal

N/A

Logo Cybin Inc. Common Stock

HELP

Cybin Inc. Common Stock

N/A

Current Price

$11.99

Market Cap

712.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NRIM
HELP
Founded
1990
N/A
Country
United States
Canada
Employees
N/A
50
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
602.6M
712.2M
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
NRIM
HELP
Price
$27.25
$11.99
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$51.50
AVG Volume (30 Days)
144.0K
2.1M
Earning Date
04-22-2026
07-01-2026
Dividend Yield
2.62%
N/A
EPS Growth
N/A
N/A
EPS
1.29
N/A
Revenue
$255,581,000.00
N/A
Revenue This Year
$4.98
N/A
Revenue Next Year
$7.40
N/A
P/E Ratio
$20.95
N/A
Revenue Growth
30.43
N/A
52 Week Low
$19.60
$3.76
52 Week High
$95.61
$11.95

Technical Indicators

Market Signals
Indicator
NRIM
HELP
Relative Strength Index (RSI) 53.84 73.76
Support Level $25.99 $4.41
Resistance Level $28.08 N/A
Average True Range (ATR) 0.51 0.80
MACD -0.02 0.22
Stochastic Oscillator 60.33 99.15

Price Performance

Historical Comparison
NRIM
HELP

About NRIM Northrim BanCorp Inc

Northrim BanCorp Inc is a bank holding company operating through three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. The Community Banking segment, which generates the majority of revenue, provides loan and deposit products to business and consumer customers in its market areas. The Home Mortgage Lending segment focuses on the origination and sale of mortgage loans for one-to-four family residential properties, mortgage loan servicing for certain loans sold, and investment in selected residential mortgage loans. The Specialty Finance segment provides factoring, asset-based lending, and alternative working capital solutions to small and medium-sized enterprises and includes SCF and Northrim Funding Services.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: